Summary & Overview
Sprains, Strains, and Dislocations of Hip, Pelvis and Thigh with CC/MCC: Inpatient Reimbursement Overview
DRG 537 covers sprains, strains, and dislocations of the hip, pelvis, and thigh when a Major Complication or Complication or Comorbidity is present; it defines the inpatient clinical scope and higher-severity resource use. This grouping matters for inpatient reimbursement because the presence of additional complications or comorbidities influences payment weight and hospital payment under Medicare.
DRG 537 Overview
DRG 537 covers inpatient hospital admissions for sprains, strains, and dislocations of the hip, pelvis, and thigh when the record includes a Major Complication or Comorbidity or a Complication or Comorbidity. This Diagnosis-Related Group captures patients with these musculoskeletal injuries who have additional clinical complexity that increases resource use. It matters for Medicare payment because cases with higher severity classifications receive higher relative reimbursement to reflect increased inpatient resources and length of stay. Accurate coding of the primary injury and any Major Complication or Complication or Comorbidity is essential for correct payment assignment.
Clinical Trials
- Acute surgical timing and perioperative pain control studies: Trials in this area focus on optimal timing of operative reduction or fixation for dislocations and severe strains/avulsion injuries of the hip, pelvis, and proximal thigh, and compare multimodal analgesia regimens (including regional blocks and opioid-sparing protocols) used in the immediate inpatient period. Patient populations are adults and older adults admitted emergently with hip/pelvic dislocations, closed pelvic ring injuries with associated muscle/tendon avulsions, or severe soft-tissue injuries classified with CC/MCC, where rapid stabilization and pain control affect morbidity. This research is relevant to providers who must balance operative urgency and anesthetic choices, and to payers because effective acute management can shorten length of stay, reduce complications, and influence resource use in high-cost inpatient DRG cases.
- Comparative effectiveness of fixation versus nonoperative management in complex proximal thigh and pelvic soft-tissue injuries: These studies compare functional outcomes, readmission rates, and complication profiles between surgical repair/repair-plus-stabilization strategies and conservative management (immobilization/rehab) for patients with severe muscle/tendon avulsions and associated bony involvement that qualify as CC/MCC. Typical study cohorts include middle-aged to elderly patients whose comorbidities and injury patterns create equipoise about the benefits of surgery versus nonoperative care, with measurement of mobility, pain, and return-to-independence over months. Findings inform clinicians about which patients derive sufficient functional benefit to justify inpatient surgical resource use, and inform payers about downstream costs, rehospitalization risk, and long-term disability related to initial management choices within this DRG.
- Post-discharge recovery, rehabilitation intensity, and readmission risk cohort studies: Observational and pragmatic trials examine how variations in inpatient rehabilitation initiation, discharge disposition (home with outpatient PT, home with home health, or skilled nursing facility), and early outpatient follow-up impact recovery trajectories, complication detection (e.g., heterotopic ossification, chronic pain), and 30- to 90-day readmission in patients with hip/pelvis/thigh sprains, strains, and dislocations coded with CC/MCC. These studies target older adults and medically complex patients whose inpatient complications or comorbidities (the CC/MCC qualifiers) increase risk of functional decline and rehospitalization, and they often use real-world outcomes and cost analyses. Results are directly applicable to case management and utilization review, helping providers optimize discharge planning and payers predict and reduce avoidable post-acute costs associated with this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.